Effects of amphetamine on rat embryos developing in vitro

Area of Science:

• Developmental toxicology
• Embryology
• Pharmacology

Background:

• Amphetamine (AMP) is a widely used stimulant with known effects on the central nervous system.
• Understanding the direct impact of AMP on early embryonic development is crucial for assessing potential risks.

Purpose of the Study:

• To investigate the direct dysmorphogenic and embryotoxic effects of in vitro exposure to amphetamine (AMP) on Wistar rat embryos.
• To determine the dose-response relationship of AMP-induced developmental toxicity.

Main Methods:

• Wistar rat embryos (Day 10.5 gestation) were cultured in vitro.
• Embryos were exposed to varying concentrations of AMP (0.1–1.6 mM) for 24 hours.
• Embryo viability, yolk sac diameter, crown-rump length, somite number, protein content, developmental score, and malformation frequency were assessed.

Main Results:

• Amphetamine (AMP) did not affect embryo viability but reduced yolk sac diameter at 1.2 and 1.6 mM.
• Significant decreases in crown-rump length, somite number, protein content, and developmental score were observed at the highest AMP concentrations.
• Increased malformation frequency, including microcephaly and neural tube defects, occurred at 1.2 and 1.6 mM AMP, along with abnormal histology.

Conclusions:

• Amphetamine (AMP) exhibits direct dose-dependent embryotoxic and dysmorphogenic effects on Wistar rat embryos in vitro.
• Observed malformations include microcephaly, neural tube defects, and spinal cord abnormalities.
• The direct dysmorphogenic impact of AMP may be less potent than that of methamphetamine.